{"id":303071,"date":"2026-10-12T16:35:56","date_gmt":"2026-10-12T11:05:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=303071"},"modified":"2026-10-12T16:35:56","modified_gmt":"2026-10-12T11:05:56","slug":"enzyme-hydration-and-diagnostic-health-stocks-future-pipeline-picks","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/enzyme-hydration-and-diagnostic-health-stocks-future-pipeline-picks\/","title":{"rendered":"3 Enzyme, Hydration and Diagnostic Health Stocks With a Strong Future Roadmap: Advanced Enzyme Technologies, FDC and Suraksha Diagnostic"},"content":{"rendered":"

Advanced Enzyme Rs 267.15, P\/E 17.28. FDC Rs 330.15, P\/E 18.05. Suraksha Diagnostic Rs 316.25, P\/E 46.05. Closing prices of 9 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Enzyme, hydration and diagnostic health stocks with the clearest long-term roadmaps today include Advanced Enzyme in enzymes and probiotics for food and pharma, FDC in oral rehydration products such as Electral and formulations and Suraksha Diagnostic in diagnostic and pathology testing. FY26 revenue growth was 16.5% at Advanced Enzyme, 3.9% at FDC and 22.5% at Suraksha Diagnostic. P\/E stands at 17.28 for Advanced Enzyme (industry 37.59), 18.05 for FDC (industry 37.59) and 46.05 for Suraksha Diagnostic (industry 62.79). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Enzyme, hydration and diagnostic health stocks give investors exposure to ingredients, health products and lab tests used in everyday healthcare. Volumes, product mix and margins decide how much of that demand turns into profit.<\/p>\n

This list covers three enzyme, hydration and diagnostic health stocks: Advanced Enzyme Technologies for enzymes and probiotics for food and pharma, FDC for oral rehydration products such as Electral and formulations and Suraksha Diagnostic for diagnostic and pathology testing. Every figure comes from the latest reported financials and the 9 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n